Canadian Tobacco, Alcohol and Drugs (CTADS) Survey: 2017 detailed tables

Table 1. Smoking status and average number of cigarettes smoked per day, by age group and sex, 2017
Table 2. Smoking status by province, age group and sex, 2017
Table 3. Nicotine dependence among daily smokers, by age group and sex, 2017
Table 4. Quit attempts in the past 12 months, by age group and sex, daily smokers, 2017
Table 5. Quit rates among ever smokers by time since quit, by age group and sex, 2017
Table 6. Cessation method(s) used by current and former smokers who made a quit attempt in the past 2 years, 2017
Table 7. Exposure of children at home to Environmental Tobacco Smoke (ETS), by province and age group, 2017
Table 8. Past-30-day use of cigarettes, any tobacco product, e-cigarettes, by age group and sex, 2017
Table 9. E-cigarette status, by age group and sex, 2017
Table 10. Past-30-day use of individual tobacco products and e-cigarettes, by age group and sex, 2017
Table 11. Mean age (in years) at first use among past-30-day users of tobacco products and e-cigarettes, by sex, 2017
Table 12. Perceived risk of harm from using cigarettes and e-cigarettes, overall and by smoking status, 2017
Table 13. Illegal drug use (past 12-month and lifetime), by age group and sex, 2017
Table 14. Psychoactive pharmaceutical drug use (past 12-month), by age group and sex, 2017
Table 15. Drug harms, by age group and sex, 2017
Table 16. Illegal drug use (past 12-month and lifetime), by province, 2017
Table 17. Alcohol indicators, by age group and sex, 2017
Table 18. Alcohol indicators, by province, 2017
Table 19. Description of the sample, Canada, 2017

Table 1. Smoking status and average number of cigarettes smoked per day, by age group and sex, 2017
Sex	Age group (years)	Population estimate ('000)	Current smokers (%)	Daily smokers (%)	Occasional smokers (%)	Former smokers (%)	Never smokers (%)	Average cigarettes smoked per day^{Footnote 1}
Total	All age groups	30,291	15.1 [13.6-16.6]	10.8 [9.5-12.1]	4.3 [3.4-5.1]	25.7 [24.0-27.5]	59.2 [57.1-61.3]	13.7 [12.6-14.7]
Male		14,950	16.7 [14.4-19.0]	11.9 [9.9-13.9]	4.8 [3.5-6.0]	29.7 [27.1-32.3]	53.7 [50.6-56.7]	14.9 [13.5-16.4]
Female		15,342	13.5^{Footnote ↓} [11.7-15.3]	9.7 [8.1-11.3]	3.8 [2.7-4.9]	21.9 [19.5-24.3]	64.6 [61.9-67.2]	12.1 [10.5-13.7]
Both sexes	15-19	2,023	7.9 [6.4-9.3]	2.9 [2.1-3.7]	4.9 [3.7-6.2]	0.5^{Footnote *,}^{Footnote ↓} [0.2-0.8]	91.6 [90.2-93.1]	9.4 [7.5-11.3]
	20-24	2,420	16.0 [14.0-18.0]	9.0 [7.4-10.5]	7.0 [5.6-8.4]	5.7 [3.9-7.6]	78.3 [75.6-80.9]	10.7 [9.4-11.9]
	25-44	9,889	17.9 [14.7-21.1]	11.9 [9.2-14.7]	6.0^{Footnote *} [4.0-8.1]	17.0 [13.7-20.4]	65.0 [60.8-69.3]	13.2 [10.9-15.4]
	25+	25,848	15.5^{Footnote ↑} [13.8-17.3]	11.6 [10.1-13.1]	4.0 [3.0-4.9]	29.6 [27.5-31.6]	54.9 [52.4-57.3]	13.9 [12.8-15.1]
	45+	15,958	14.1 [12.2-15.9]	11.4 [9.7-13.0]	2.7^{Footnote *} [1.8-3.6]	37.4 [34.8-40.0]	48.6 [45.8-51.4]	14.5^{Footnote ↓} [13.3-15.7]
Male	15-19	1,040	9.7 [7.3-12.2]	3.8^{Footnote *} [2.4-5.2]	5.9^{Footnote *} [3.8-8.0]	^{Footnote #}	89.7 [87.3-92.2]	9.7 [7.0-12.3]
	20-24	1,244	20.4 [17.2-23.5]	11.2 [8.9-13.4]	9.2 [6.9-11.5]	7.5^{Footnote *,} ^{Footnote ↑} [4.7-10.4]	72.1 [68.1-76.1]	12.1 [10.3-13.9]
	25-44	4,931	17.9 [13.2-22.6]	12.1^{Footnote *} [8.1-16.1]	5.9^{Footnote *} [3.0-8.7]	20.6 [15.2-25.9]	61.5^{Footnote ↑} [54.9-68.1]	13.9 [11.1-16.7]
	25+	12,665	16.9 [14.2-19.6]	12.6 [10.3-15.0]	4.3^{Footnote *} [2.8-5.7]	34.2 [31.2-37.3]	48.9 [45.3-52.5]	15.3 [13.7-16.9]
	45+	7,734	16.2 [13.2-19.3]	13.0 [10.3-15.7]	3.2^{Footnote *} [1.7-4.8]	42.9 [39.1-46.8]	40.8 [36.7-44.9]	16.1 [14.3-17.9]
Female	15-19	983	5.9 [4.4-7.4]	2.0^{Footnote *} [1.3-2.8]	3.9^{Footnote *} [2.5-5.3]	^{Footnote #}	93.6 [92.1-95.2]	9.0 [6.2-11.8]
	20-24	1,177	11.4 [8.9-13.9]	6.6 [4.5-8.7]	4.8 [3.4-6.2]	3.9^{Footnote *} [1.7-6.0]	84.8 [81.5-88.0]	8.2 [6.6-9.7]
	25-44	4,958	17.9 [13.6-22.3]	11.7 [8.1-15.4]	6.2^{Footnote *} [3.3-9.1]	13.5^{Footnote ↑} [9.7-17.4]	68.5^{Footnote ↑} [63.2-73.8]	12.4 [8.7-16.0]
	25+	13,182	14.3 [12.1-16.4]	10.5^{Footnote ↑} [8.7-12.4]	3.7^{Footnote *} [2.5-4.9]	25.1 [22.4-27.9]	60.6 [57.5-63.7]	12.4 [10.6-14.1]
	45+	8,224	12.0 [9.8-14.3]	9.8 [7.8-11.9]	2.2^{Footnote *} [1.2-3.2]	32.1 [28.4-35.8]	55.9 [52.0-59.7]	12.4 [10.8-13.9]
[95% confidence intervals in brackets] Table 1 Note 1 Daily smokers only. Return to table 1 note 1 referrer Table 1 Note * Moderate sampling variability, interpret with caution. Return to table 1 note * referrer Table 1 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 1 note # referrer Table 1 Note ↑ Rounds up to whole number. Return to table 1 note ↑ referrer Table 1 Note↓ Rounds down to whole number. Return to table 1 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 2. Smoking status by province, age group and sex, 2017
Smoking Status	Canada	NL	PE	NS	NB	QC	ON	MB	SK	AB	BC
Population estimate ('000)	30,291	448	124	808	636	6,987	11,763	1,066	924	3,478	4,057
Current smokers
Total	15.1 [13.6-16.6]	20.0 [14.7-25.3]	11.8 [8.2-15.4]	18.4 [14.3-22.6]	13.7 [10.0-17.5]	15.7 [12.4-19.1]	12.9 [10.4-15.4]	14.5^{Footnote ↓} [10.6-18.3]	17.8 [13.9-21.6]	18.9 [14.8-22.9]	15.6 [11.4-19.8]
15-19	7.9 [6.4-9.3]	10.0^{Footnote *} [5.6-14.4]	15.8^{Footnote *} [9.2-22.3]	9.7^{Footnote *} [4.8-14.6]	5.8^{Footnote *} [3.3-8.2]	8.3^{Footnote *} [5.4-11.1]	6.4^{Footnote *} [3.9-8.8]	14.2^{Footnote *} [5.4-22.9]	21.9^{Footnote *} [12.0-31.8]	7.0^{Footnote *} [3.9-10.2]	6.5^{Footnote *} ^{Footnote ↑} [2.8-10.3]
20-24	16.0 [14.0-18.0]	24.2^{Footnote *} [11.6-36.8]	16.2^{Footnote *} [9.2-23.2]	19.6^{Footnote *} [12.1-27.2]	20.1 [13.6-26.5]	19.6 [15.2-24.1]	12.3 [9.1-15.5]	21.1 [14.8-27.5]	23.4^{Footnote *} [15.7-31.0]	21.1^{Footnote *} [14.0-28.1]	11.7^{Footnote *} [4.9-18.5]
25-44	17.9 [14.7-21.1]	^{Footnote #}	^{Footnote #}	25.8^{Footnote *} [14.8-36.7]	11.0^{Footnote *} [5.0-16.9]	20.6^{Footnote *} [13.0-28.3]	14.3^{Footnote *} [9.0-19.6]	^{Footnote #}	^{Footnote #}	25.1^{Footnote *} [16.8-33.3]	^{Footnote #}
25+	15.5^{Footnote ↑} [13.8-17.3]	20.4 [14.4-26.4]	11.1^{Footnote *} [6.9-15.3]	19.0 [14.2-23.8]	13.8 [9.6-18.1]	15.9 [12.1-19.7]	13.5^{Footnote ↓} [10.6-16.4]	13.8^{Footnote *} [9.2-18.4]	16.9 [12.3-21.4]	19.6 [14.9-24.3]	16.7 [11.8-21.6]
45+	14.1 [12.2-15.9]	19.6^{Footnote *} [13.1-26.1]	^{Footnote #}	15.6 [11.3-19.9]	15.2^{Footnote *} [9.5-20.9]	13.2 [9.0-17.3]	13.0 [9.7-16.3]	10.2^{Footnote *} [5.8-14.6]	19.2 [13.1-25.4]	15.0^{Footnote *} [9.3-20.7]	16.8 [11.6-22.0]
Male (15+)	16.7 [14.4-19.0]	21.6^{Footnote *} [13.7-29.6]	13.3^{Footnote *} [8.0-18.6]	25.3 [18.4-32.2]	13.9^{Footnote *} [8.3-19.6]	17.4 [12.1-22.8]	15.9 [12.0-19.8]	16.4^{Footnote *} [10.5-22.3]	17.6^{Footnote *} [11.6-23.6]	18.6 [13.0-24.2]	14.2^{Footnote *} [9.1-19.2]
Female (15+)	13.5^{Footnote ↓} [11.7-15.3]	18.5^{Footnote *} ^{Footnote ↑} [11.6-25.4]	10.3^{Footnote *} [5.2-15.5]	12.0^{Footnote *} [7.5-16.4]	13.5^{Footnote *} ^{Footnote ↑} [8.2-18.9]	14.1 [10.0-18.2]	10.0 [7.1-13.0]	12.5^{Footnote *} ^{Footnote ↑} [8.0-17.1]	18.0 [13.2-22.8]	19.1 [13.1-25.2]	17.0^{Footnote *} [10.5-23.5]
Former smokers
Total	25.7 [24.0-27.5]	29.6 [24.0-35.2]	29.9 [24.3-35.5]	32.3 [27.6-37.1]	28.6 [23.6-33.5]	30.5^{Footnote ↑} [26.6-34.4]	23.1 [20.1-26.2]	25.2 [21.3-29.0]	25.5^{Footnote ↑} [20.7-30.3]	21.1 [17.0-25.1]	27.0 [21.9-32.0]
15-19	0.5^{Footnote *} ^{Footnote ↓} [0.2-0.8]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
20-24	5.7 [3.9-7.6]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	4.8^{Footnote *} [2.6-6.9]	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	11.6^{Footnote *} [5.3-18.0]
25-44	17.0 [13.7-20.4]	15.6^{Footnote *} [6.3-24.8]	^{Footnote #}	^{Footnote #}	14.4^{Footnote *} [7.6-21.2]	19.9^{Footnote *} [12.7-27.1]	14.7^{Footnote *} [8.9-20.4]	^{Footnote #}	24.6^{Footnote *} [16.2-32.9]	15.2^{Footnote *} [9.3-21.1]	^{Footnote #}
25+	29.6 [27.5-31.6]	33.4 [27.0-39.7]	34.1 [27.6-40.7]	37.0 [31.5-42.4]	32.5^{Footnote ↓} [26.8-38.2]	34.8 [30.2-39.3]	26.8 [23.2-30.4]	29.9 [25.3-34.6]	29.6 [23.9-35.3]	24.4 [19.6-29.1]	30.5^{Footnote ↓} [24.6-36.3]
45+	37.4 [34.8-40.0]	41.9 [33.5-50.3]	38.9 [30.8-46.9]	44.7 [38.0-51.3]	41.1 [33.0-49.2]	43.4 [37.3-49.5]	34.2 [29.7-38.8]	42.8 [35.9-49.7]	33.2 [25.6-40.9]	32.2 [25.1-39.3]	36.3 [29.6-43.0]
Male (15+)	29.7 [27.1-32.3]	31.3 [22.8-39.9]	33.4 [24.7-42.0]	32.1 [25.2-39.1]	31.4 [23.8-39.0]	33.0 [27.1-38.8]	29.1 [24.4-33.8]	26.4 [20.8-31.9]	25.6 [17.8-33.3]	24.4 [18.7-30.2]	30.8 [22.1-39.6]
Female (15+)	21.9 [19.5-24.3]	28.0 [20.7-35.2]	26.6 [18.8-34.3]	32.5^{Footnote ↑} [25.8-39.3]	25.8 [19.5-32.1]	28.1 [22.3-33.9]	17.4 [13.5-21.4]	24.0 [18.5-29.4]	25.5^{Footnote ↓} [19.5-31.4]	17.6 [12.5-22.7]	23.2 [17.3-29.1]
Never smokers
Total	59.2 [57.1-61.3]	50.4 [44.3-56.4]	58.3 [51.9-64.7]	49.2 [44.3-54.1]	57.7 [52.2-63.2]	53.7 [49.3-58.1]	64.0 [60.5-67.5]	60.4 [55.6-65.2]	56.7 [51.4-62.0]	60.1 [55.2-65.0]	57.4 [51.1-63.8]
15-19	91.6 [90.2-93.1]	85.7 [79.8-91.5]	83.3 [76.5-90.1]	89.8 [84.8-94.7]	93.6 [90.9-96.2]	91.3 [88.4-94.2]	93.3 [90.8-95.7]	85.7 [76.9-94.4]	77.3 [67.5-87.1]	92.5^{Footnote ↑} [89.3-95.7]	93.0 [89.2-96.9]
20-24	78.3 [75.6-80.9]	73.9 [61.3-86.5]	75.8 [67.9-83.7]	74.4 [66.1-82.8]	75.0 [68.3-81.6]	75.6 [70.9-80.3]	82.6 [78.0-87.2]	75.9 [69.4-82.3]	69.9 [61.9-77.9]	74.9 [67.8-82.0]	76.7 [67.7-85.7]
25-44	65.0 [60.8-69.3]	62.4 [50.3-74.5]	59.6 [44.4-74.8]	52.7 [40.6-64.7]	74.6 [65.9-83.3]	59.5^{Footnote ↓} [49.6-69.3]	71.1 [63.7-78.4]	70.0 [60.2-79.7]	61.9 [52.9-70.9]	59.8 [51.2-68.3]	63.1 [49.4-76.8]
25+	54.9 [52.4-57.3]	46.2 [39.4-53.1]	54.8 [47.3-62.2]	44.1 [38.3-49.8]	53.7 [47.5-60.0]	49.3 [44.3-54.4]	59.7 [55.6-63.9]	56.3 [50.6-62.0]	53.5^{Footnote ↑} [47.3-59.7]	56.0 [50.3-61.8]	52.9 [45.5-60.2]
45+	48.6 [45.8-51.4]	38.5^{Footnote ↓} [30.4-46.6]	52.4 [43.8-61.1]	39.7 [33.3-46.1]	43.7 [35.3-52.2]	43.4 [37.3-49.5]	52.8 [48.1-57.6]	47.1 [40.1-54.0]	47.5^{Footnote ↑} [39.3-55.7]	52.8 [45.3-60.3]	47.0 [39.6-54.3]
Male (15+)	53.7 [50.6-56.7]	47.1 [38.0-56.2]	53.3 [43.9-62.7]	42.6 [35.1-50.1]	54.7 [46.6-62.7]	49.6 [42.9-56.3]	55.0 [49.5-60.4]	57.2 [49.7-64.7]	56.9 [48.7-65.0]	57.0 [50.9-63.1]	55.0 [45.6-64.4]
Female (15+)	64.6 [61.9-67.2]	53.5^{Footnote ↑} [45.5-61.6]	63.1 [54.5-71.7]	55.5^{Footnote ↑} [48.9-62.1]	60.6 [53.4-67.9]	57.8 [51.5-64.1]	72.5^{Footnote ↑} [68.2-76.9]	63.5^{Footnote ↓} [57.2-69.8]	56.5^{Footnote ↑} [50.0-63.1]	63.2 [55.7-70.8]	59.8 [51.7-67.9]
[95% confidence intervals in brackets] Table 2 Note * Moderate sampling variability, interpret with caution. Return to table 2 note * referrer Table 2 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 2 note # referrer Table 2 Note ↑ Rounds up to whole number. Return to table 2 note ↑ referrer Table 2 Note↓ Rounds down to whole number. Return to table 2 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 3. Nicotine dependence among daily smokers, by age group and sex, 2017
Sex	Age group (years)	Population estimate ('000)	How soon after waking do you have your first cigarette?
Sex	Age group (years)	Population estimate ('000)	Within 5 minutes (%)	6-30 minutes (%)	31-60 minutes (%)	>60 minutes (%)
Total	All age groups	3,236	15.2 [10.6-19.8]	34.4 [28.9-40.0]	23.2 [17.8-28.6]	27.2 [21.3-33.0]
Male		1,751	11.2^{Footnote *} [7.0-15.4]	39.5^{Footnote ↑} [31.2-47.9]	23.7 [16.1-31.3]	25.5^{Footnote ↓} [17.5-33.5]
Female		1,485	19.9^{Footnote *} [11.4-28.4]	28.4 [20.6-36.2]	22.5^{Footnote *} ^{Footnote ↑} [14.5-30.5]	29.1 [20.5-37.7]
Both sexes	15-19	59	^{Footnote #}	19.3^{Footnote *} [10.2-28.5]	21.0^{Footnote *} [11.1-30.9]	44.2 [30.2-58.3]
	20-24	215	8.9^{Footnote *} [5.1-12.8]	23.6 [16.1-31.0]	28.2^{Footnote *} [18.7-37.6]	39.3 [30.0-48.6]
	25-44	1,169	^{Footnote #}	29.4^{Footnote *} [18.2-40.6]	24.2^{Footnote *} [14.1-34.3]	33.8^{Footnote *} [22.6-45.0]
	25+	2,961	15.7 [10.7-20.7]	35.5^{Footnote ↑} [29.5-41.6]	22.9 [17.0-28.7]	25.9 [19.6-32.2]
	45+	1,793	17.7^{Footnote *} [11.8-23.6]	39.5^{Footnote ↑} [32.0-47.1]	22.0^{Footnote *} [14.7-29.3]	20.8^{Footnote *} [13.9-27.7]
[95% confidence intervals in brackets] Table 3 Note * Moderate sampling variability, interpret with caution. Return to table 3 note * referrer Table 3 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 3 note # referrer Table 3 Note ↑ Rounds up to whole number. Return to table 3 note ↑ referrer Table 3 Note↓ Rounds down to whole number. Return to table 3 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 4. Quit attempts in the past 12 months, by age group and sex, daily smokers, 2017
Sex	Age group (years)	Population estimate ('000)	No attempts (%)	1 attempt (%)	2-3 attempts (%)	4 or more attempts (%)
Total	All age groups	3,214	55.6 [49.1-62.1]	15.9 [10.8-21.0]	16.3 [11.6-21.0]	12.1 [8.3-16.0]
Male		1,736	56.2 [47.3-65.1]	12.0^{Footnote *} [5.8-18.2]	19.1^{Footnote *} [12.0-26.2]	12.7^{Footnote *} [7.2-18.2]
Female		1,478	55.0 [45.7-64.3]	20.5^{Footnote *} ^{Footnote ↑} [11.6-29.5]	13.0^{Footnote *} [7.3-18.8]	11.4^{Footnote *} [5.9-17.0]
Both sexes	15-19	58	39.0^{Footnote *} [24.8-53.1]	^{Footnote #}	21.4^{Footnote *} [10.6-32.2]	30.3^{Footnote *} [16.5-44.0]
	20-24	212	42.2 [33.0-51.5]	16.0^{Footnote *} [10.1-22.0]	21.8^{Footnote *} [13.2-30.3]	20.0^{Footnote *} [12.6-27.4]
	25-44	1,169	49.3 [37.5-61.1]	24.2^{Footnote *} [12.1-36.2]	13.5^{Footnote *} ^{Footnote ↓} [6.4-20.6]	13.0^{Footnote *} [5.0-21.0]
	25+	2,944	56.9 [50.0-63.9]	16.0^{Footnote *} [10.5-21.6]	15.8 [10.8-20.9]	11.2^{Footnote *} [7.0-15.4]
	45+	1,774	61.9 [53.7-70.2]	10.7^{Footnote *} [6.1-15.3]	17.4^{Footnote *} [10.5-24.3]	10.0^{Footnote *} [5.3-14.7]
Male	15-19	39	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
	20-24	134	49.5^{Footnote ↑} [38.1-61.0]	13.3^{Footnote *} [7.3-19.2]	17.3^{Footnote *} [10.4-24.2]	19.9^{Footnote *} [9.7-30.0]
	25-44	593	51.6 [35.0-68.2]	^{Footnote #}	^{Footnote #}	^{Footnote #}
	25+	1,563	57.2 [47.5-67.0]	11.9^{Footnote *} [5.0-18.8]	19.1^{Footnote *} [11.3-27.0]	11.7^{Footnote *} [5.7-17.7]
	45+	970	60.6 [49.0-72.3]	^{Footnote #}	21.3^{Footnote *} [10.3-32.2]	11.5^{Footnote *} ^{Footnote ↓} [4.7-18.3]
Female	15-19	20	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
	20-24	78	29.7^{Footnote *} [16.2-43.1]	20.8^{Footnote *} [8.2-33.4]	29.4^{Footnote *} [11.6-47.3]	20.1^{Footnote *} [8.9-31.3]
	25-44	576	47.0^{Footnote *} [29.4-64.6]	^{Footnote #}	^{Footnote #}	^{Footnote #}
	25+	1,380	56.6 [46.7-66.5]	20.7^{Footnote *} [11.2-30.2]	12.1^{Footnote *} [6.2-18.0]	10.6^{Footnote *} [4.7-16.6]
	45+	804	63.5^{Footnote ↑} [53.1-73.9]	^{Footnote #}	12.7^{Footnote *} [5.7-19.6]	^{Footnote #}
[95% confidence intervals in brackets] Table 4 Note * Moderate sampling variability, interpret with caution. Return to table 4 note * referrer Table 4 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 4 note # referrer Table 4 Note ↑ Rounds up to whole number. Return to table 4 note ↑ referrer Table 4 Note↓ Rounds down to whole number. Return to table 4 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 5. Quit rates among ever smokers by time since quit, by age group and sex, 2017
Sex	Age group (years)	Population estimate ('000)	Total quitters (%)	Short term quitters^{Footnote 1} (%)	Long term quitters^{Footnote 2} (%)
Total	All age groups	12,334	63.0 [60.0-66.0]	3.7 [2.6-4.9]	59.2 [56.3-62.2]
Male		6,926	64.0 [59.9-68.1]	4.5^{Footnote *} ^{Footnote ↑} [2.8-6.3]	59.5^{Footnote ↓} [55.4-63.6]
Female		5,408	61.7 [57.2-66.3]	2.8^{Footnote *} [1.5-4.1]	58.9 [54.4-63.5]
Both sexes	15-19	169	5.8^{Footnote *} [2.4-9.1]	^{Footnote #}	^{Footnote #}
	20-24	522	25.8 [19.1-32.6]	6.0^{Footnote *} [3.0-9.0]	19.8^{Footnote *} [13.0-26.7]
	25-44	3,460	48.7 [41.6-55.8]	7.4^{Footnote *} [4.0-10.9]	41.3 [34.4-48.1]
	25+	11,643	65.5^{Footnote ↓} [62.3-68.6]	3.7^{Footnote *} [2.4-4.9]	61.8 [58.7-65.0]
	45+	8,184	72.6 [69.3-75.8]	2.1^{Footnote *} [1.2-2.9]	70.5 ^{Footnote ↑} [67.2-73.8]
Male	15-19	107	^{Footnote #}	^{Footnote #}	^{Footnote #}
	20-24	347	26.9 [18.5-35.4]	6.7^{Footnote *} [2.3-11.1]	20.2^{Footnote *} [11.6-28.8]
	25-44	1,898	53.4 [43.7-63.1]	^{Footnote #}	43.5^{Footnote ↓} [34.0-52.9]
	25+	6,473	66.9 [62.6-71.3]	4.4^{Footnote *} [2.6-6.3]	62.5 ^{Footnote ↑} [58.2-66.9]
	45+	4,575	72.6 [67.9-77.2]	2.2^{Footnote *} [0.9-3.4]	70.4 [65.7-75.1]
Female	15-19	62	^{Footnote #}	^{Footnote #}	^{Footnote #}
	20-24	175	23.6^{Footnote *} [12.2-35.0]	4.5^{Footnote *} ^{Footnote ↑} [2.2-6.9]	19.1^{Footnote *} [7.5-30.7]
	25-44	1,561	43.0 [33.0-53.0]	^{Footnote #}	38.6 [28.8-48.3]
	25+	5,170	63.7 [58.9-68.4]	2.7^{Footnote *} [1.3-4.0]	61.0 [56.2-65.7]
	45+	3,609	72.6 [67.8-77.4]	^{Footnote #}	70.7 [65.8-75.6]
[95% confidence intervals in brackets] Table 5 Note 1 Short term quitter - a former smoker who quit smoking less than one year prior to the survey. Determined by their response to the question, "When did you stop smoking? Was it less than 1 year ago, 1 to 2 years ago, 3 to 5 years ago, or more than 5 years ago?" Return to table 5 note 1 referrer Table 5 Note 2 Long term quitter - a former smoker who quit smoking a year or more ago and has not resumed smoking during that time frame. Determined by their response to the question, "When did you stop smoking? Was it less than 1 year ago, 1 to 2 years ago, 3 to 5 years ago, or more than 5 years ago?" Return to table 5 note 2 referrer Table 5 Note * Moderate sampling variability, interpret with caution. Return to table 5 note * referrer Table 5 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 5 note # referrer Table 5 Note ↑ Rounds up to whole number. Return to table 5 note ↑ referrer Table 5 Note↓ Rounds down to whole number. Return to table 5 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 6. Cessation method(s)^{Footnote 1} used by current^{Footnote 2} and former^{Footnote 3} smokers who made a quit attempt in the past 2 years, 2017
	E-cigarette (%)	Nicotine patch (%)	Nicotine gum (%)	Medication (%)	Deal w/ friend or family member (%)	Reduced # of cigarettes (%)
Total	32.4 [26.6-38.2]	24.3 [18.8-29.9]	16.1 [11.9-20.3]	14.7 [10.0-19.5]	23.2 [18.3-28.0]	62.6 [56.4-68.8]
Current smokers	32.5^{Footnote ↑} [25.6-39.4]	25.9 [19.2-32.6]	17.1 [11.9-22.2]	12.4^{Footnote *} [7.4-17.3]	22.8 [17.3-28.2]	72.8 [66.1-79.5]
Former smokers	31.9 [21.8-42.1]	20.3^{Footnote *} [11.5-29.0]	13.5^{Footnote *} ^{Footnote ↓} [7.0-20.0]	21.1^{Footnote *} [10.8-31.3]	24.3^{Footnote *} [14.1-34.6]	36.9 [26.1-47.7]
[95% confidence intervals in brackets] Table 6 Note 1 Respondents could provide more than one cessation method. Return to table 6 note 1 referrer Table 6 Note 2 Includes current smokers who attempted to quit smoking cigarettes in the past 2 years. Return to table 6 note 2 referrer Table 6 Note 3 Includes former smokers who successfully quit in the past 2 years. Return to table 6 note 3 referrer Table 6 Note * Moderate sampling variability, interpret with caution. Return to table 6 note * referrer Table 6 Note ↑ Rounds up to whole number. Return to table 6 note ↑ referrer Table 6 Note↓ Rounds down to whole number. Return to table 6 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 7. Exposure of children at home to Environmental Tobacco Smoke (ETS), by province and age group, 2017
Province	% Children aged 0-11 regularly exposed	% Children aged 12-17 regularly exposed	% Children aged 0-17 regularly exposed
Canada	1.1^{Footnote *} [0.8-1.6]	2.7 [2.0-3.5]	1.7 [1.3-2.1]
Newfoundland and Labrador	^{Footnote #}	^{Footnote #}	^{Footnote #}
Prince Edward Island	^{Footnote #}	^{Footnote #}	2.0^{Footnote *} [1.1-3.5]
Nova Scotia	^{Footnote #}	4.4^{Footnote *} [2.6-7.2]	3.1^{Footnote *} [1.8-5.4]
New Brunswick	^{Footnote #}	6.1^{Footnote *} [3.6-10.2]	2.8^{Footnote *} [1.7-4.6]
Quebec	^{Footnote #}	^{Footnote #}	2.2^{Footnote *} [1.5-3.3]
Ontario	^{Footnote #}	^{Footnote #}	1.7^{Footnote *} [1.0-2.9]
Manitoba	^{Footnote #}	^{Footnote #}	^{Footnote #}
Saskatchewan	^{Footnote #}	4.6^{Footnote *} [2.8-7.5]	2.7^{Footnote *} [1.7-4.3]
Alberta	^{Footnote #}	^{Footnote #}	^{Footnote #}
British Columbia	^{Footnote #}	^{Footnote #}	^{Footnote #}
[Wilson score intervals in brackets] Table 7 Note * Moderate sampling variability, interpret with caution. Return to table 7 note * referrer Table 7 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 7 note # referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 8. Past-30-day use of cigarettes, any tobacco product, e-cigarettes, by age group and sex, 2017
Sex	Age group (years)	Cigarettes^{Footnote 1} (%)	Any Tobacco Product^{Footnote 2} (%)	E-cigarettes (%)
Total	All age groups	15.3 [13.8-16.8]	17.8 [16.2-19.3]	2.9 [2.3-3.5]
Male		17.0 [14.7-19.3]	21.2 [18.6-23.8]	3.6 [2.7-4.5]
Female		13.6 [11.8-15.5]	14.4 [12.5-16.4]	2.2^{Footnote *} [1.4-2.9]
Both sexes	15-19	6.6 [5.3-7.9]	9.2 [7.7-10.7]	6.3 [5.0-7.5]
	20-24	15.6 [13.6-17.6]	20.6 [18.2-23.1]	6.0 [4.8-7.3]
	25+	16.0 [14.3-17.7]	18.2 [16.3-20.0]	2.3 [1.6-3.0]
	25-44	18.7 [15.6-21.9]	22.4 [19.0-25.8]	3.2^{Footnote *} [1.8-4.6]
	45+	14.2 [12.4-16.1]	15.6 [13.6-17.5]	1.7^{Footnote *} [1.1-2.4]
Male	15-19	8.4 [6.1-10.7]	12.3 [9.7-14.9]	8.1 [6.1-10.1]
	20-24	20.0 [16.8-23.2]	26.5^{Footnote ↓} [22.9-30.1]	9.5^{Footnote ↓} [7.1-11.8]
	25+	17.4 [14.7-20.1]	21.4 [18.4-24.4]	2.6^{Footnote *} [1.6-3.6]
	25-44	19.6 [14.8-24.3]	25.9 [20.5-31.3]	3.7^{Footnote *} [1.7-5.7]
	45+	16.1 [13.0-19.2]	18.6 [15.3-21.8]	2.0^{Footnote *} [0.9-3.0]
Female	15-19	4.8 [3.5-6.0]	5.9 [4.5-7.3]	4.4 [3.0-5.7]
	20-24	10.9 [8.5-13.3]	14.4 [11.3-17.5]	2.5^{Footnote *} ^{Footnote ↓} [1.5-3.4]
	25+	14.5^{Footnote ↑} [12.4-16.7]	15.1 [12.9-17.3]	2.0^{Footnote *} [1.1-2.8]
	25-44	17.9 [13.6-22.2]	18.9 [14.5-23.4]	^{Footnote #}
	45+	12.5^{Footnote ↑} [10.1-14.9]	12.8 [10.3-15.2]	1.5^{Footnote *} ^{Footnote ↑} [0.9-2.2]
[95% confidence intervals in brackets] Table 8 Note 1 A past-30-day smoker has smoked one or more cigarettes in the past 30 days. This includes current smokers as well as some former, and never smokers who have smoked a cigarette in the past 30 days Return to table 8 note 1 referrer Table 8 Note 2 Any tobacco product includes past-30-day use of cigarettes including menthol, little cigars or cigarillos, cigars, pipe, chewing tobacco, pinch or snuff, and/or a waterpipe with tobacco. E-cigarettes are excluded. Return to table 8 note 2 referrer Table 8 Note * Moderate sampling variability, interpret with caution. Return to table 8 note * referrer Table 8 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 8 note # referrer Table 8 Note ↑ Rounds up to whole number. Return to table 8 note ↑ referrer Table 8 Note↓ Rounds down to whole number. Return to table 8 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 9. E-cigarette status, by age group and sex, 2017
Sex	Age group (years)	Ever tried (%)	Daily^{Footnote 1} (%)	Occasional^{Footnote 1} (%)
Total	All age groups	15.4 [14.0-16.7]	0.8^{Footnote *} [0.5-1.0]	2.3 [1.7-2.8]
Male		18.8 [16.6-21.0]	1.3^{Footnote *} [0.8-1.8]	2.4 [1.7-3.2]
Female		12.0 [10.4-13.6]	0.3^{Footnote *} [0.1-0.4]	2.1^{Footnote *} [1.4-2.8]
Both sexes	15-19	22.8 [20.6-24.9]	1.6^{Footnote *} [1.0-2.1]	5.1 [4.1-6.2]
	20-24	29.3 [26.9-31.7]	1.3^{Footnote *} [0.7-1.9]	4.7 [3.5-5.9]
	25-44	21.8 [18.5-25.0]	1.2^{Footnote *} [0.5-2.0]	1.9^{Footnote *} [0.7-3.0]
	25+	13.5^{Footnote ↓} [11.9-15.0]	0.7^{Footnote *} [0.4-1.0]	1.8^{Footnote *} [1.2-2.4]
	45+	8.4 [6.9-9.8]	^{Footnote #}	1.8^{Footnote *} [1.1-2.5]
Male	15-19	28.0 [24.3-31.8]	2.5^{Footnote *} ^{Footnote ↑} [1.4-3.6]	5.5^{Footnote ↑} [4.1-7.0]
	20-24	37.4 [33.5-41.3]	2.1^{Footnote *} [1.1-3.1]	7.1 [4.9-9.3]
	25-44	27.7 [22.0-33.3]	^{Footnote #}	^{Footnote #}
	25+	16.2 [13.7-18.8]	1.1^{Footnote *} [0.5-1.7]	1.7^{Footnote *} [0.9-2.6]
	45+	8.9 [6.8-11.1]	^{Footnote #}	^{Footnote #}
Female	15-19	17.2 [14.8-19.7]	^{Footnote #}	4.7 [3.2-6.2]
	20-24	20.7 [17.7-23.7]	^{Footnote #}	2.2^{Footnote *} [1.4-3.0]
	25-44	15.9 [12.1-19.7]	^{Footnote #}	^{Footnote #}
	25+	10.8 [9.0-12.7]	^{Footnote #}	1.9^{Footnote *} [1.1-2.7]
	45+	7.8 [6.0-9.7]	^{Footnote #}	1.7^{Footnote *} [0.9-2.6]
[95% confidence intervals in brackets] Table 9 Note 1 Daily and occasional users are ever-users of e-cigarettes who provided a response to the question "At the present time, do you use an electronic cigarette, also known as an e-cigarette, every day, occasionally or not at all". Return to table 9 note 1 referrer Table 9 Note * Moderate sampling variability, interpret with caution. Return to table 9 note * referrer Table 9 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 9 note # referrer Table 9 Note ↑ Rounds up to whole number. Return to table 9 note ↑ referrer Table 9 Note↓ Rounds down to whole number. Return to table 9 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 10. Past-30-day use of individual tobacco products and e-cigarettes, by age group and sex, 2017
Sex	Age group (years)	Any tobacco product^{Footnote 1} (%)	Cigarettes^{Footnote 2} (%)	Cigars (%)	Little cigars or cigarillos (%)	Pipe (%)	Smokeless tobacco (%)	Water-pipe w/tobacco (%)	E-cigarettes (%)
Total	All age groups	17.8 [16.2-19.3]	15.3 [13.8-16.8]	0.8^{Footnote *} [0.5-1.1]	1.4 [1.0-1.8]	0.3^{Footnote *} [0.1-0.5]	0.7^{Footnote *} [0.3-1.2]	0.7^{Footnote *} [0.4-0.9]	2.9 [2.3-3.5]
Male		21.2 [18.6-23.8]	17.0 [14.7-19.3]	1.5^{Footnote *},^{Footnote ↓} [0.9-2.1]	2.1 [1.4-2.8]	^{Footnote #}	1.5^{Footnote *,}^{Footnote ↑} [0.7-2.3]	0.9^{Footnote *} [0.5-1.3]	3.6 [2.7-4.5]
Female		14.4 [12.5-16.4]	13.6 [11.8-15.5]	0.1^{Footnote *} [0.0-0.1]	^{Footnote #}	^{Footnote #}	^{Footnote #}	0.5^{Footnote *,}^{Footnote ↑} [0.2-0.9]	2.2^{Footnote *} [1.4-2.9]
Both sexes	15-19	9.2 [7.7-10.7]	6.6 [5.3-7.9]	1.0^{Footnote *} [0.6-1.4]	2.2^{Footnote *} [1.1-3.3]	^{Footnote #}	1.6^{Footnote *} [0.7-2.6]	1.5^{Footnote *,}^{Footnote ↓} [0.9-2.1]	6.3 [5.0-7.5]
	20-24	20.6 [18.2-23.1]	15.6 [13.6-17.6]	2.1 [1.5-2.7]	3.7^{Footnote *} [2.3-5.1]	^{Footnote #}	1.4^{Footnote *} [0.9-2.0]	3.1^{Footnote *} [1.9-4.4]	6.0 [4.8-7.3]
	25-44	22.4 [19.0-25.8]	18.7 [15.6-21.9]	^{Footnote #}	1.9^{Footnote *} [0.9-3.0]	^{Footnote #}	^{Footnote #}	^{Footnote #}	3.2^{Footnote *} [1.8-4.6]
	25+	18.2 [16.3-20.0]	16.0 [14.3-17.7]	0.6^{Footnote *} [0.3-1.0]	1.1^{Footnote *} [0.7-1.5]	^{Footnote #}	^{Footnote #}	^{Footnote #}	2.3 [1.6-3.0]
	45+	15.6 [13.6-17.5]	14.2 [12.4-16.1]	^{Footnote #}	0.6^{Footnote *} [0.3-0.9]	^{Footnote #}	^{Footnote #}	^{Footnote #}	1.7^{Footnote *} [1.1-2.4]
[95% confidence intervals in brackets] Table 10 Note 1 Any tobacco product includes past-30-day use of cigarettes (including menthol), little cigars or cigarillos, cigars, pipe, chewing tobacco, pinch or snuff, and/or a waterpipe with tobacco. E-cigarettes are excluded. Return to table 10 note 1 referrer Table 10 Note 2 A past-30-day smoker has smoked one or more cigarettes in the past 30 days. This includes current smokers as well as some former, and never smokers who have smoked a cigarette in the past 30 days. Return to table 10 note 2 referrer Table 10 Note * Moderate sampling variability, interpret with caution. Return to table 10 note * referrer Table 10 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 10 note # referrer Table 10 Note ↑ Rounds up to whole number. Return to table 10 note ↑ referrer Table 10 Note↓ Rounds down to whole number. Return to table 10 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 11. Mean age (in years) at first use among past-30-day users of tobacco products and e-cigarettes, by sex, 2017
	Cigarettes (in years)	Little cigars or cigarillos (in years)	Cigars (in years)	Tobacco pipe (in years)	Smokeless tobacco (in years)	Water-pipe w/ tobacco (in years)	E-cigarettes (in years)
Total	16.0 [15.5-16.5]	21.2 [18.7-23.7]	22.5^{Footnote ↓} [18.9-26.0]	26.8 [20.4-33.2]	22.6 [16.9-28.2]	18.0 [16.4-19.7]	34.1 [31.1-37.0]
Male	16.3 [15.6-17.0]	21.2 [19.1-23.4]	22.5^{Footnote ↑} [18.8-26.3]	27.7 [20.1-35.4]	22.6 [16.9-28.3]	17.4 [15.2-19.5]	32.3 [28.8-35.7]
Female	15.6 [14.9-16.4]	21.3^{Footnote *} [13.2-29.4]	21.7 [14.9-28.5]	^{Footnote #}	^{Footnote #}	19.1 [17.0-21.1]	36.9 [31.5-42.4]
[95% confidence intervals in brackets] Table 11 Note * Moderate sampling variability, interpret with caution. Return to table 11 note * referrer Table 11 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 11 note # referrer Table 11 Note ↑ Rounds up to whole number. Return to table 11 note ↑ referrer Table 11 Note↓ Rounds down to whole number. Return to table 11 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 12. Perceived risk of harm from using cigarettes and e-cigarettes, overall and by smoking status, 2017
	Total (%)	Current smokers (%)	Former smokers (%)	Never smokers (%)
Smoking cigarettes once in a while
No risk	3.6 [2.8-4.3]	3.8^{Footnote *} [2.4-5.3]	4.8^{Footnote *} [3.2-6.5]	3.0 [2.1-3.8]
Slight risk	28.6 [26.7-30.5]	37.5^{Footnote ↑} [32.1-42.9]	30.1 [26.2-33.9]	25.8 [23.4-28.2]
Moderate risk	34.1 [32.2-36.0]	32.5^{Footnote ↑} [27.6-37.5]	27.8 [24.4-31.1]	37.2 [34.7-39.8]
Great risk	30.3 [28.5-32.2]	21.3 [16.9-25.7]	34.4 [30.3-38.5]	30.8 [28.3-33.2]
Don't know	3.4 [2.6-4.2]	4.9^{Footnote *} [2.4-7.3]	2.9^{Footnote *} [1.6-4.2]	3.2^{Footnote *} [2.1-4.3]
Smoking cigarettes on a regular basis
No risk	0.7^{Footnote *} [0.3-1.0]	^{Footnote #}	^{Footnote #}	0.6^{Footnote *} [0.3-0.9]
Slight risk	1.4^{Footnote *} [0.9-1.9]	3.7^{Footnote *} [1.7-5.7]	^{Footnote #}	0.7^{Footnote *} [0.4-1.0]
Moderate risk	10.6 [9.3-11.9]	18.5^{Footnote ↓} [14.5-22.4]	8.9 [6.3-11.5]	9.3 [7.9-10.8]
Great risk	85.3 [83.8-86.8]	74.1 [69.4-78.7]	86.9 [83.8-90.0]	87.5^{Footnote ↓} [85.7-89.2]
Don't know	2.1 [1.4-2.7]	^{Footnote #}	2.1^{Footnote *} [0.9-3.3]	1.9^{Footnote *} [1.1-2.7]
Using e-cigarettes once in a while
No risk	6.5^{Footnote ↑} [5.6-7.4]	12.5^{Footnote ↓} [9.4-15.5]	5.2^{Footnote *} [3.5-7.0]	5.6 [4.5-6.7]
Slight risk	22.4 [20.8-24.1]	28.7 [24.0-33.4]	19.3 [16.0-22.5]	22.3 [20.3-24.2]
Moderate risk	27.9 [26.0-29.8]	24.3 [19.4-29.2]	23.9 [20.7-27.2]	30.6 [28.0-33.1]
Great risk	19.8 [18.1-21.6]	13.1 [9.2-17.0]	20.0 [16.7-23.3]	21.5^{Footnote ↓} [19.2-23.7]
Don't know	23.3 [21.5-25.1]	21.5^{Footnote ↓} [17.4-25.6]	31.6 [27.8-35.4]	20.1 [17.8-22.4]
Using e-cigarettes on a regular basis
No risk	2.4 [1.8-2.9]	4.1^{Footnote *} [2.3-5.9]	1.9^{Footnote *} [1.0-2.8]	2.2^{Footnote *} [1.4-2.9]
Slight risk	8.4 [7.4-9.4]	13.8 [10.6-17.0]	6.5^{Footnote ↓} [4.5-8.4]	7.9 [6.6-9.2]
Moderate risk	24.7 [23.1-26.3]	32.6 [27.5-37.7]	18.6 [15.6-21.7]	25.3 [23.2-27.4]
Great risk	40.4 [38.4-42.3]	26.4 [21.7-31.2]	39.3 [35.4-43.2]	44.4 [41.8-46.9]
Don't know	24.1 [22.4-25.9]	23.1 [19.0-27.2]	33.7 [29.8-37.7]	20.2 [18.0-22.5]
[95% confidence intervals in brackets] Table 12 Note * Moderate sampling variability, interpret with caution. Return to table 12 note * referrer Table 12 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 12 note # referrer Table 12 Note ↑ Rounds up to whole number. Return to table 12 note ↑ referrer Table 12 Note↓ Rounds down to whole number. Return to table 12 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 13. Illegal drug use (past 12-month and lifetime), by age group and sex, 2017
Drug Category	Overall	Males	Females	15-19	20-24	25+
Population estimate ('000)	30,291	14,950	15,342	2,023	2,420	25,848
Cannabis use
Cannabis - lifetime	46.6 [44.3 -48.8]	52.4 [49.1 -55.7]	40.9 [37.9 -44.0]	26.9 [24.5 -29.3]	52.6 [49.4 -55.9]	47.6 [44.9 -50.2]
Cannabis - past year	14.8 [13.2 -16.4]	18.7 [16.0 -21.4]	11.1 [9.3 -12.9]	19.4 [17.4 -21.4]	33.2 [30.3 -36.2]	12.7 [10.9 -14.6]
Median age of initiation (years)	17.0 [16.4 -16.9]	17.0 [16.7 -17.3]	17.0 [16.7 -17.3]	16.0 [15.7 -16.3]	17.0 [15.7 -16.3]	18.0 [17.7 -18.3]
Mean age of initiation (years)	18.6 [18.1 -19.1]	18.3 [17.7 -18.9]	19.1 [18.3 -19.8]	15.6 [15.4 -15.8]	17.0 [16.7 -17.2]	18.9 [18.4 -19.5]
Illegal drug use past year
Cocaine/Crack	2.5 ^{Footnote *} ^{Footnote ↓} [1.5 -3.4]	3.7^{Footnote *} [1.9 -5.5]	1.3^{Footnote *} [0.7 -1.8]	1.6^{Footnote *} [1.0 -2.2]	6.2 [4.6 -7.9]	2.2^{Footnote *} [1.1 -3.3]
Speed/Methamphetamine/Crystal meth	^{Footnote #}	^{Footnote #}	0.08^{Footnote *} [0.0 -0.1]	^{Footnote #}	1.3^{Footnote *} [0.6 -2.1]	^{Footnote #}
Hallucinogens	1.5 ^{Footnote *,}^{Footnote ↓} [0.9 -2.1]	2.3^{Footnote *} [1.1 -3.6]	0.7^{Footnote *} [0.3 -1.0]	2.7 [1.9 -3.5]	5.1 [3.7 -6.5]	^{Footnote #}
Hallucinogens (including salvia)	1.5^{Footnote ↑} [0.9 -2.1]	2.4^{Footnote *} [1.1 -3.6]	0.7^{Footnote *} [0.3 -1.0]	2.8 [2.0 -3.6]	5.1 [3.7 -6.5]	^{Footnote #}
Ecstasy	0.9^{Footnote *} [0.4 -1.5]	^{Footnote #}	0.6^{Footnote *} [0.2 -1.0]	1.6^{Footnote *} [0.8 -2.4]	3.1 [2.2 -4.0]	^{Footnote #}
Salvia	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Heroin	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Any of 6 drugs (hallucinogens excl. salvia)^{Footnote 1}	15.2 [13.6 -16.9]	19.3 [16.6 -22.0]	11.3 [9.5 -13.1]	19.9 [17.8 -21.9]	34.9 [31.9 -37.9]	13.0 [11.1 -14.9]
Any of 5 drugs (hallucinogens excl. salvia)^{Footnote 2}	3.3 [2.4 -4.3]	4.9^{Footnote *} [3.1 -6.8]	1.8^{Footnote *} [1.1 -2.4]	4.1 [3.1 -5.1]	10.3 [8.3 -12.3]	2.6^{Footnote *} [1.5 -3.8]
Any of 6 drugs (hallucinogens incl. salvia)^{Footnote 1}	15.2 [13.6 -16.9]	19.3 [16.6 -22.0]	11.3 [9.5 -13.1]	19.9 [17.8 -21.9]	34.9 [31.9 -37.9]	13.0 [11.1 -14.9]
Any of 5 drugs (hallucinogens incl. salvia)^{Footnote 2}	3.3 [2.4 -4.3]	5.0^{Footnote *} [3.1 -6.8]	1.8^{Footnote *} [1.1 -2.4]	4.1 [3.1 -5.1]	10.3 [8.3 -12.3]	2.6^{Footnote *} [1.5 -3.8]
Any drug^{Footnote 3}	15.7 [14.1 -17.4]	19.9 [17.1 -22.6]	11.8 [9.9 -13.6]	20.7 [18.6 -22.8]	35.5^{Footnote ↓} [32.4 -38.5]	13.5^{Footnote ↑} [11.6 -15.4]
Lifetime illegal drug use
Cocaine/Crack	10.4 [9.0 -11.9]	14.5^{Footnote ↑} [12.0 -17.1]	6.5^{Footnote ↓} [5.1 -7.9]	2.6 [1.8 -3.3]	12.5^{Footnote ↓} [10.1 -14.8]	10.9 [9.2 -12.6]
Speed/Methamphetamine/Crystal meth	3.7 [2.8 -4.6]	5.4 [3.7 -7.0]	2.2^{Footnote *} [1.4 -2.9]	1.0^{Footnote *} [0.5 -1.5]	3.8 [2.9 -4.8]	3.9 [2.9 -5.0]
Hallucinogens	14.3 [12.6 -15.9]	18.6 [15.9 -21.3]	10.0 [8.0 -12.0]	4.2 [3.3 -5.2]	14.0 [11.7 -16.3]	15.1 [13.1 -17.0]
Hallucinogens (including salvia)	14.8 [13.1 -16.5]	19.2 [16.5 -21.9]	10.6 [8.6 -12.6]	4.4 [3.4 -5.4]	16.2 [13.8 -18.5]	15.5^{Footnote ↑} [13.6 -17.5]
Ecstasy	7.6 [6.2 -9.0]	9.0 [6.8 -11.3]	6.2 [4.4 -8.0]	3.0 [2.0 -3.9]	12.7 [10.7 -14.7]	7.5^{Footnote ↑} [5.8 -9.2]
Salvia	2.9 [2.0 -3.8]	3.6^{Footnote *} [2.2 -5.0]	2.2^{Footnote *} [1.0 -3.3]	0.8^{Footnote *} [0.5 -1.1]	7.1 [5.8 -8.5]	2.6^{Footnote *} [1.6 -3.7]
Heroin	0.7^{Footnote *} [0.3 -1.1]	1.0^{Footnote *} [0.4 -1.6]	^{Footnote #}	^{Footnote #}	^{Footnote #}	0.8^{Footnote *} [0.4 -1.2]
Any of 6 drugs (hallucinogens excl. salvia)^{Footnote 1}	47.3 [45.1 -49.6]	53.3 [50.0 -56.5]	41.6 [38.5 -44.7]	27.1 [24.7 -29.4]	53.2 [49.9 -56.5]	48.4 [45.8 -51.0]
Any of 5 drugs (hallucinogens excl. salvia)^{Footnote 2}	18.5^{Footnote ↑} [16.7 -20.4]	23.4 [20.5 -26.3]	13.8 [11.6 -16.1]	6.1 [4.9 -7.3]	22.0 [19.3 -24.7]	19.2 [17.1 -21.3]
Any of 6 drugs (hallucinogens incl. salvia)^{Footnote 1}	47.2 [45.0 -49.5]	53.3 [50.0 -56.6]	41.6 [38.5 -44.7]	27.1 [24.7 -29.4]	53.2 [50.0 -56.5]	48.4 [45.8 -51.0]
Any of 5 drugs (hallucinogens incl. salvia)^{Footnote 2}	18.9 [17.1 -20.8]	23.8 [20.9 -26.7]	14.2 [12.0 -16.5]	6.2 [5.0 -7.4]	23.3 [20.6 -26.0]	19.5^{Footnote ↑} [17.4 -21.7]
Any drug^{Footnote 4}	47.9 [45.6 -50.1]	53.8 [50.6 -57.1]	42.1 [39.0 -45.2]	27.5^{Footnote ↓} [25.1 -29.9]	53.4 [50.1 -56.7]	48.9 [46.3 -51.6]
[95% confidence intervals in brackets] Table 13 Note 1 Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin. Return to table 13 note 1 referrer Table 13 Note 2 Cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin. Return to table 13 note 2 referrer Table 13 Note 3 Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers, stimulants; sedatives to get high. Return to table 13 note 3 referrer Table 13 Note 4 Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, salvia, inhalants, heroin; abuse of pain relievers to get high. Return to table 13 note 4 referrer Table 13 Note * Moderate sampling variability, interpret with caution. Return to table 13 note * referrer Table 13 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 13 note # referrer Table 13 Note ↑ Rounds up to whole number. Return to table 13 note ↑ referrer Table 13 Note↓ Rounds down to whole number. Return to table 13 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 14. Psychoactive pharmaceutical drug use (past 12-month), by age group and sex, 2017
Pharmaceutical Drug Category	Overall	Males	Females	15-19	20-24	25+
Population estimate ('000)	30,291	14,950	15,342	2,023	2,420	25,848
Pain Relievers
Pain relievers	11.8 [10.6 -13.0]	11.2 [9.4 -13.0]	12.4 [10.7 -14.1]	8.4 [6.9 -9.9]	12.0 [9.9 -14.1]	12.1 [10.6 -13.5]
Pain relievers to get high	^{Footnote #}	0.4^{Footnote *} [0.2 -0.6]	^{Footnote #}	0.8^{Footnote *} [0.3 -1.2]	1.1^{Footnote *} [0.4 -1.7]	^{Footnote #}
Pain relievers to get high - among those who have used pain relievers	1.8^{Footnote *} [0.9 -2.8]	3.0^{Footnote *} [1.1 -4.9]	^{Footnote #}	4.5^{Footnote *,}^{Footnote ↑} [2.0 -7.0]	^{Footnote #}	^{Footnote #}
Problematic use of pain relievers (includes to get high)	^{Footnote #}	0.5^{Footnote *,}^{Footnote ↑} [0.3 -0.8]	^{Footnote #}	0.9^{Footnote *} [0.4 -1.4]	^{Footnote #}	^{Footnote #}
Problematic use of pain relievers (includes to get high) - among those who have used pain relievers	2.9^{Footnote *} [1.6 -4.2]	3.8^{Footnote *} [1.7 -5.9]	^{Footnote #}	5.5^{Footnote *,}^{Footnote ↓} [2.8 -8.2]	^{Footnote #}	1.9^{Footnote *} [0.7 -3.1]
Stimulants
Stimulants	2.4^{Footnote *} [1.6 -3.2]	2.9^{Footnote *} [1.6 -4.1]	2.0^{Footnote *} [0.9 -3.1]	5.4 [4.5 -6.4]	5.5^{Footnote ↓} [4.4 -6.5]	1.9^{Footnote *} [0.9 -2.8]
Stimulants to get high	0.2^{Footnote *} [0.1 -0.3]	^{Footnote #}	0.1^{Footnote *} [0.0 -0.1]	^{Footnote #}	1.0^{Footnote *} [0.5 -1.5]	^{Footnote #}
Stimulants to get high - among those who have used stimulants	^{Footnote #}	^{Footnote #}	^{Footnote #}	9.0^{Footnote *} [3.3 -14.8]	18.4^{Footnote *} [9.9 -26.9]	^{Footnote #}
Problematic use of stimulants (includes to get high)	0.3^{Footnote *} [0.2 -0.5]	0.6^{Footnote *} [0.2 -0.9]	0.1^{Footnote *} [0.1 -0.2]	0.9^{Footnote *} [0.5 -1.3]	1.9^{Footnote *} [1.2 -2.5]	^{Footnote #}
Problematic use of stimulants (includes to get high) - among those who have used stimulants	18.8^{Footnote *} [10.2 -27.4]	23.9^{Footnote *} [10.1 -37.7]	10.4^{Footnote *} [5.1 -15.6]	18.0^{Footnote *} [10.8 -25.2]	41.0 [29.9 -52.1]	^{Footnote #}
Sedatives
Sedatives	11.7 [10.3 -13.2]	9.1 [7.2 -10.9]	14.3 [12.1 -16.5]	5.1 [4.1 -6.0]	7.5^{Footnote ↑} [6.3 -8.7]	12.6 [10.9 -14.3]
Sedatives to get high	0.2^{Footnote *} [0.1 -0.2]	0.2^{Footnote *} [0.1 -0.3]	^{Footnote #}	0.8^{Footnote *} [0.4 -1.2]	0.8^{Footnote *} [0.3 -1.3]	^{Footnote #}
Sedatives to get high - among those who have used sedatives	1.4^{Footnote *} [0.8 -2.1]	2.3^{Footnote *} [1.0 -3.5]	^{Footnote #}	15.3^{Footnote *} [7.8 -22.8]	10.8^{Footnote *} [4.9 -16.8]	^{Footnote #}
Any Pharmaceutical
Any pharmaceutical	22.2 [20.4 -24.0]	19.9 [17.4 -22.5]	24.4 [21.8 -26.9]	16.8 [15.0 -18.7]	21.2 [18.8 -23.7]	22.7 [20.6 -24.8]
Any pharmaceutical to get high	^{Footnote #}	0.7^{Footnote *} [0.4 -1.1]	^{Footnote #}	1.6^{Footnote *} [1.0 -2.1]	2.2^{Footnote *} [1.4 -3.0]	^{Footnote #}
Any pharmaceutical to get high - among those who have used any pharmaceutical	^{Footnote #}	3.7^{Footnote *} [2.0 -5.3]	^{Footnote #}	8.7^{Footnote *} [5.5 -11.9]	9.8^{Footnote *} [6.0 -13.6]	^{Footnote #}
Problematic use of any pharmaceutical (includes to get high)	1.2^{Footnote *} [0.6 -1.7]	1.1^{Footnote *} [0.7 -1.5]	^{Footnote #}	2.1^{Footnote *} [1.4 -2.7]	3.6^{Footnote *} [2.3 -4.9]	^{Footnote #}
Problematic use of any pharmaceutical to get high - among those who have used any pharmaceutical	4.8^{Footnote *} [2.3 -7.3]	5.6^{Footnote *} [3.5 -7.7]	^{Footnote #}	11.8 [8.3 -15.3]	17.1^{Footnote *} [11.4 -22.8]	^{Footnote #}
[95% confidence intervals in brackets] Table 14 Note * Moderate sampling variability, interpret with caution. Return to table 14 note * referrer Table 14 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 14 note # referrer Table 14 Note ↑ Rounds up to whole number. Return to table 14 note ↑ referrer Table 14 Note↓ Rounds down to whole number. Return to table 14 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 15. Drug harms, by age group and sex, 2017
Drug related harms in past year^{Footnote 1}	Overall	Males	Females	15-19	20-24	25+
Population estimate ('000)	30,291	14,950	15,342	2,023	2,420	25,848
Any drug harm to self - total population	4.1 [3.1 -5.1]	5.5^{Footnote *}^{Footnote ↑} [3.7 -7.3]	2.9^{Footnote *} [1.9 -3.9]	5.4 [4.4 -6.5]	10.1 [8.2 -12.1]	3.3^{Footnote *} [2.1 -4.5]
Any drug harm to self among those who have used any of 5 drugs^{Footnote 2}	39.6^{Footnote *} [25.2 -53.9]	37.2^{Footnote *} [18.7 -55.8]	45.5^{Footnote *}^{Footnote ↑} [27.6 -63.4]	53.2^{Footnote *} [40.7 -65.7]	38.0^{Footnote *} [28.6 -47.3]	38.4^{Footnote *} [17.1 -59.8]
Any drug harm to self among those who have engaged in problematic use of pharmaceuticals^{Footnote 3}	29.2^{Footnote *} [12.5 -45.9]	39.8^{Footnote *} [22.8 -56.7]	^{Footnote #}	37.5^{Footnote ↑} [23.7 -51.3]	52.5^{Footnote *}^{Footnote ↑} [33.9 -71.2]	^{Footnote #}
Any drug harm to self among those who have used/engaged in problematic use of any drugs^{Footnote 4}	18.3 [14.1 -22.5]	18.8 [13.0 -24.6]	17.5^{Footnote ↑} [11.9 -23.2]	24.6 [20.2 -28.9]	23.5^{Footnote *}^{Footnote ↓} [19.3 -27.6]	16.2 [10.6 -21.8]
[95% confidence intervals in brackets] Table 15 Note 1 At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems. Return to table 15 note 1 referrer Table 15 Note 2 Among those who have used any of 5 drugs (cocaine/crack, speed/methamphetamine/crystal meth, hallucinogens including salvia, ecstasy, heroin) in the past year. Drug related harms in the past year are due to any drug use. Users of any 5 drugs may also have used other drugs, including cannabis, or misused pharmaceuticals. Return to table 15 note 2 referrer Table 15 Note 3 Among those who have engaged in problematic use of pharmaceuticals (abuse of pain killers, abuse of stimulants, sedatives to get high) in the past year. Drug related harms in the past year are due to any drug use. Misusers of pharmaceuticals may also have used illegal drugs. Return to table 15 note 3 referrer Table 15 Note 4 Among those who have used any drug (cannabis, cocaine/crack, speed/methamphetamine/crystal meth, hallucinogens including salvia, ecstasy, inhalants, heroin, misuse of pain killers, misuse of stimulants, sedatives to get high) in the past year. Return to table 15 note 4 referrer Table 15 Note * Moderate sampling variability, interpret with caution. Return to table 15 note * referrer Table 15 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 15 note # referrer Table 15 Note ↑ Rounds up to whole number. Return to table 15 note ↑ referrer Table 15 Note↓ Rounds down to whole number. Return to table 15 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 16. Illegal drug use (past 12-month and lifetime), by province, 2017
Drug Category / Indicator	Canada	NL	PE	NS	NB	QC	ON	MB	SK	AB	BC
Population estimate ('000)	30,291	448	124	808	636	6,987	11,763	1,066	924	3,478	4,057
Cannabis use
Cannabis - lifetime	46.6	44.7	46.8	52.1	47.2	43.0	44.9	42.4	44.2	49.2	55.8
Cannabis - past year	14.8	11.9	14.6	18.8	13.2	11.0	14.0	15.7	12.5^{Footnote ↓}	15.0	23.4
Illegal drug use past year
Cocaine/Crack	2.5^{Footnote *,}^{Footnote ↓}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	1.5^{Footnote *,}^{Footnote ↓}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Speed/Methamphetamine/Crystal meth	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Hallucinogens	1.5^{Footnote *,}^{Footnote ↓}	^{Footnote #}	0.2^{Footnote *}	^{Footnote #}	^{Footnote #}	0.4^{Footnote *}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Ecstasy	0.9^{Footnote *}	^{Footnote #}	^{Footnote #}	0.2^{Footnote *}	^{Footnote #}	^{Footnote #}	0.3^{Footnote *}	^{Footnote #}	^{Footnote #}	^{Footnote #}	1.4^{Footnote *}
Salvia	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Heroin	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Any of 6 drugs (hallucinogens excl. salvia)^{Footnote 1}	15.2	12.7	14.6	18.8	13.4	11.7	14.3	15.8	12.6	15.6	23.8
Any of 5 drugs (hallucinogens excl. salvia)^{Footnote 2}	3.3	^{Footnote #}	^{Footnote #}	2.6^{Footnote *}	0.9^{Footnote *}	3.0^{Footnote *}	3.0^{Footnote *}	^{Footnote #}	2.1^{Footnote *}	3.9^{Footnote *}	^{Footnote #}
Any drug^{Footnote 3}	15.7	13.2	15.0	19.0	14.2	12.3	14.7	16.3	14.2	15.9	24.4
Lifetime illegal drug use
Cocaine/Crack	10.4	7.2^{Footnote *}	5.7^{Footnote *}	11.7^{Footnote *}	4.6^{Footnote *}	10.8	7.8	9.5^{Footnote *,}^{Footnote ↓}	9.6^{Footnote *}	10.2	19.2
Speed/Methamphetamine/Crystal meth	3.7	^{Footnote #}	^{Footnote #}	^{Footnote #}	4.0^{Footnote *}	6.5^{Footnote *,}^{Footnote ↓}	2.7^{Footnote *}	^{Footnote #}	1.8^{Footnote *}	2.9^{Footnote *}	^{Footnote #}
Hallucinogens	14.3	10.7^{Footnote *}	11.0^{Footnote *}	16.6	11.9^{Footnote *}	11.5^{Footnote ↓}	11.8	14.1^{Footnote *}	11.1	18.2	23.8
Ecstasy	7.6	4.8^{Footnote *}	3.9^{Footnote *}	6.7^{Footnote *}	3.2^{Footnote *}	8.2^{Footnote *}	5.7^{Footnote *}	5.5^{Footnote *}^{Footnote ↓}	3.8^{Footnote *}	9.8^{Footnote *}	13.0^{Footnote *}
Salvia	2.9	^{Footnote #}	^{Footnote #}	4.2^{Footnote *}	2.9^{Footnote *}	1.8^{Footnote *}	2.8^{Footnote *}	3.0^{Footnote *}	^{Footnote #}	3.3^{Footnote *}	^{Footnote #}
Heroin	0.7^{Footnote *}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}	^{Footnote #}
Any of 6 drugs (hallucinogens excl. salvia)^{Footnote 1}	47.3	45.2	46.9	52.4	48.2	44.9	45.1	42.7	45.7	49.5^{Footnote *,}^{Footnote ↓}	56.7
Any of 5 drugs (hallucinogens excl. salvia)^{Footnote 2}	18.5^{Footnote ↑}	12.2^{Footnote *}	12.4^{Footnote *}	20.5^{Footnote *,}^{Footnote ↓}	15.4	18.5^{Footnote *,}^{Footnote ↑}	14.9	16.9	15.4	22.1	28.3
Any drug^{Footnote 3}	47.9	45.5^{Footnote ↓}	47.4	52.7	48.3	45.7	45.5^{Footnote ↓}	44.5^{Footnote ↑}	46.6	49.8	57.2
Drug related harms in past year^{Footnote 4}
Any drug harm to self - total population^{Footnote 5}	4.1	^{Footnote #}	^{Footnote #}	3.5^{Footnote *,}^{Footnote ↑}	2.4^{Footnote *}	3.6^{Footnote *}	4.0^{Footnote *}	2.1^{Footnote *}	5.4^{Footnote *}	3.9^{Footnote *}	6.6^{Footnote *}
[95% confidence intervals in brackets] Table 16 Note 1 Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin. Return to table 16 note 1 referrer Table 16 Note 2 Cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, heroin. Return to table 16 note 2 referrer Table 16 Note 3 Cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens, salvia, heroin, inhalants, problematic use of pain relievers to get high. Return to table 16 note 3 referrer Table 16 Note 4 At least one of 8 harms to: physical health; friendships and social life; financial position; home life or marriage; work, studies, or employment opportunities; legal problems; difficulty learning; housing problems. Return to table 16 note 4 referrer Table 16 Note 5 Asked of those who used any drug (cannabis, cocaine/crack, speed/methamphetamine/crystal meth, ecstasy, hallucinogens including salvia, heroin, inhalants, problematic use of pain relievers, stimulants and sedatives to get high); present among total population. Return to table 16 note 5 referrer Table 16 Note * Moderate sampling variability, interpret with caution. Return to table 16 note * referrer Table 16 Note # High sampling variability - although an estimate may be determined from the table, data should be suppressed. Return to table 16 note # referrer Table 16 Note ↑ Rounds up to whole number. Return to table 16 note ↑ referrer Table 16 Note↓ Rounds down to whole number. Return to table 16 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 17. Alcohol indicators, by age group and sex, 2017
Alcohol indicator	Overall	Males	Females	15-19	20-24	25+
Population estimate ('000)	30,291	14,950	15,342	2,023	2,420	25,848
Alcohol
Lifetime use	90.3 [89.1 -91.4]	91.6 [90.0 -93.2]	89.0 [87.3 -90.7]	64.2 [61.7 -66.7]	88.3 [84.9 -91.6]	92.5^{Footnote ↑} [91.2 -93.8]
Past 12 month use	78.2 [76.5 -79.9]	79.5^{Footnote ↓} [76.9 -82.0]	76.9 [74.6 -79.3]	56.8 [54.1 -59.5]	83.5^{Footnote ↓} [80.1 -86.8]	79.4 [77.4 -81.3]
Mean age of initiation (years)	18.3 [18.0 -18.5]	17.7 [17.3 -18.0]	18.9 [18.5 -19.3]	15.8 [15.7 -16.0]	16.9 [16.8 -17.1]	18.5^{Footnote ↑} [18.3 -18.8]
Exceeding low-risk drinking guidelines (LRDG)^{Footnote 1}
Exceeds LRDG chronic	16.1 [14.4 -17.8]	17.6 [15.0 -20.3]	14.6 [12.5 -16.8]	10.3 [7.8 -12.8]	24.1 [21.4 -26.7]	15.8 [13.8 -17.8]
Exceeds LRDG acute	11.5^{Footnote ↓} [10.0 -13.0]	13.1 [10.8 -15.3]	9.9 [8.1 -11.8]	6.6 [5.3 -7.9]	19.6 [17.1 -22.2]	11.1 [9.4 -12.8]
Exceeds LRDG chronic - among those who drink	20.8 [18.6 -22.9]	22.3 [19.1 -25.6]	19.2 [16.4 -21.9]	18.4 [14.3 -22.5]	28.9 [26.0 -31.9]	20.1 [17.6 -22.5]
Exceeds LRDG acute - among those who drink	14.8 [13.0 -16.7]	16.6 [13.8 -19.4]	13.0 [10.6 -15.5]	11.8 [9.5 -14.1]	23.6 [20.8 -26.5]	14.1 [12.0 -16.3]
[95% confidence intervals in brackets] Table 17 Note 1 Based on alcohol consumption in the previous 7 days. Return to table 17 note 1 referrer Table 17 Note ↑ Rounds up to whole number. Return to table 17 note ↑ referrer Table 17 Note↓ Rounds down to whole number. Return to table 17 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 18. Alcohol indicators, by province, 2017
Alcohol indicator	Canada	NL	PE	NS	NB	QC	ON	MB	SK	AB	BC
Population estimate ('000)	30,291	448	124	808	636	6,987	11,763	1,066	924	3,478	4,057
Alcohol
Lifetime use	90.3	91.7	91.4	92.7	90.3	93.7	88.3	87.8	91.3	89.3	90.9
Past 12 month use	78.2	77.4	68.4	73.8	74.9	84.2	75.6	71.0	78.4	78.8	78.5^{Footnote ↓}
Exceeding low-risk drinking guidelines (LRDG)^{Footnote 1}
Exceeds LRDG chronic	16.1	18.4	18.4	17.0	14.4	16.6	15.8	14.4	11.1	14.5^{Footnote ↓}	18.8
Exceeds LRDG acute	11.5^{Footnote ↓}	14.0^{Footnote *}	15.1^{Footnote *}	13.8^{Footnote *}	12.3	12.6	10.2	11.0^{Footnote *}	9.5^{Footnote *}^{Footnote ↑}	8.9	15.2^{Footnote *}
Exceeds LRDG chronic - among those who drink	20.8	23.8	27.1	23.2	19.4	19.8	21.1	20.5^{Footnote ↓}	14.3	18.5^{Footnote ↓}	24.1
Exceeds LRDG acute - among those who drink	14.8	18.1	22.3^{Footnote *}	18.9	16.4	15.0	13.6	15.7^{Footnote *}	12.2^{Footnote *}	11.4	19.4^{Footnote *}
[95% confidence intervals in brackets] Table 18 Note 1 Based on alcohol consumption in the previous 7 days. Return to table 18 note 1 referrer Table 18 Note * Moderate sampling variability, interpret with caution. Return to table 18 note * referrer Table 18 Note ↑ Rounds up to whole number. Return to table 18 note ↑ referrer Table 18 Note↓ Rounds down to whole number. Return to table 18 note ↓ referrer Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Table 19. Description of the sample, Canada, 2017
	Canada	NL	PE	NS	NB	QC	ON	MB	SK	AB	BC
Male	7,847	664	519	578	727	994	1,738	656	564	710	697
Female	8,502	691	561	662	787	1,086	1,898	712	633	734	738
15-19	5,072	466	330	371	487	604	1,124	416	355	496	423
20-24	5,250	393	321	363	444	704	1,265	490	377	434	459
25+	6,027	496	429	506	583	772	1,247	462	465	514	553
25-34	809	56	46	66	69	104	169	64	77	90	68
35-44	991	82	49	59	107	130	201	81	86	108	88
45-54	1,824	192	146	145	192	221	391	131	120	134	152
55+	2,403	166	188	236	215	317	486	186	182	182	245
Total	16,349	1,355	1,080	1,240	1,514	2,080	3,636	1,368	1,197	1,444	1,435
Source: Canadian Tobacco, Alcohol and Drugs Survey, February - December 2017.

Page details

Date modified:: 2021-08-12

Language selection

Search

Canadian Tobacco, Alcohol and Drugs (CTADS) Survey: 2017 detailed tables

Table of Contents

Page details